Loading...
MEDNAX reported a net loss of $41.0 million, or $0.49 per share, for the third quarter of 2020. On a non-GAAP basis, Adjusted EPS from continuing operations was $0.37. Net revenue from continuing operations was $461 million.
Net revenue of $461 million from continuing operations.
Net loss of $41.0 million, or $0.49 per share.
Adjusted EPS from continuing operations of $0.37.
Definitive agreement to sell MEDNAX Radiology Solutions was announced.
No forward guidance provided in the earnings report.
Analyze how earnings announcements historically affect stock price performance